Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus

por Dejaco, Christian, Duftner, Christina, Cimmino, Marco A, Dasgupta, Bhaskar, Salvarani, Carlo, Crowson, Cynthia S, Maradit-Kremers, Hilal, Hutchings, Andrew, Matteson, Eric L, Schirmer, Michael
Publicado 2010

Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Re...

por Soliman, Moetaza M, Ashcroft, Darren M, Watson, Kath D, Lunt, Mark, Symmons, Deborah P M, Hyrich, Kimme L
Publicado 2011

The PTPN22*C1858T functional polymorphism is associated with susceptibility to inflammatory polyarthritis but neither this nor other variants spanning the gene is associated with d...

por Naseem, H, Thomson, W, Silman, A, Worthington, J, Symmons, D, Barton, A
Publicado 2008

The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel

por Burmester, Gerd, Lanas, Angel, Biasucci, Luigi, Hermann, Matthias, Lohmander, Stefan, Olivieri, Ignazio, Scarpignato, Carmelo, Smolen, Josef, Hawkey, Chris, Bajkowski, Adam, Berenbaum, Francis, Breedveld, Ferdinand, Dieleman, Peter, Dougados, Maxime, MacDonald, Thomas, Mola, Emilio Martin, Mets, Tony, Van Den Noortgate, Nele, Stoevelaar, Herman
Publicado 2010

Predicting the outcome of ankylosing spondylitis therapy

por Vastesaeger, Nathan, van der Heijde, Désirée, Inman, Robert D, Wang, Yanxin, Deodhar, Atul, Hsu, Benjamin, Rahman, Mahboob U, Dijkmans, Ben, Geusens, Piet, Vander Cruyssen, Bert, Collantes, Eduardo, Sieper, Joachim, Braun, Jürgen
Publicado 2011

Concepts of functioning and health important to people with systemic sclerosis: a qualitative study in four European countries

por Stamm, Tanja A, Mattsson, Malin, Mihai, Carina, Stöcker, Juliane, Binder, Alexa, Bauernfeind, Bettina, Stummvoll, Georg, Gard, Gunvor, Hesselstrand, Roger, Sandqvist, Gunnel, Draghicescu, Oana, Gherghe, Ana Maria, Voicu, Malina, Machold, Klaus P, Distler, Oliver, Smolen, Josef S, Boström, Carina
Publicado 2011

Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomi...

por Wildi, Lukas Martin, Raynauld, Jean-Pierre, Martel-Pelletier, Johanne, Beaulieu, André, Bessette, Louis, Morin, Frédéric, Abram, François, Dorais, Marc, Pelletier, Jean-Pierre
Publicado 2011

Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis

por Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Tatsuki, Yoshihiko, Yano, Toshiro, Yoshinari, Toru, Abe, Tohru, Koike, Takao
Publicado 2011

Progression of lumbar disc degeneration over a decade: a heritability study

por Williams, Frances M K, Popham, Maria, Sambrook, Philip N, Jones, Annette F, Spector, Tim D, MacGregor, Alex J
Publicado 2011

Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis

por Hinks, Anne, Moncrieffe, Halima, Martin, Paul, Ursu, Simona, Lal, Sham, Kassoumeri, Laura, Weiler, Tracey, Glass, David N, Thompson, Susan D, Wedderburn, Lucy R, Thomson, Wendy
Publicado 2011

In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: re...

por Verstappen, Suzanne M M, Lunt, Mark, Bunn, Diane K, Scott, David G I, Symmons, Deborah P M
Publicado 2011

Diagnostic performance of the ACR/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH)

por Alves, Celina, Luime, Jolanda Jacoba, van Zeben, Derkjen, Huisman, Anne-Margriet, Weel, Angelique Elisabeth Adriana Maria, Barendregt, Pieternella Johanna, Hazes, Johanna Maria Wilhelmina
Publicado 2011

Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis

por Bowes, John, Orozco, Gisela, Flynn, Edward, Ho, Pauline, Brier, Rasha, Marzo-Ortega, Helena, Coates, Laura, McManus, Ross, Ryan, Anthony W, Kane, David, Korendowych, Eleanor, McHugh, Neil, FitzGerald, Oliver, Packham, Jonathan, Morgan, Ann W, Bruce, Ian N, Barton, Anne
Publicado 2011

Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register

por Galloway, J B, Hyrich, K L, Mercer, L K, Dixon, W G, Ustianowski, A P, Helbert, M, Watson, K D, Lunt, M, Symmons, D P M
Publicado 2011

Lumbar disc degeneration and genetic factors are the main risk factors for low back pain in women: the UK Twin Spine Study

por Livshits, Gregory, Popham, Maria, Malkin, Ida, Sambrook, Philip N, MacGregor, Alex J, Spector, Timothy, Williams, Frances M K
Publicado 2011

Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis

por Yeo, Lorraine, Toellner, Kai-Michael, Salmon, Mike, Filer, Andrew, Buckley, Christopher D, Raza, Karim, Scheel-Toellner, Dagmar
Publicado 2011

Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire

por Haraoui, Boulos, Smolen, Josef S, Aletaha, Daniel, Breedveld, Ferdinand C, Burmester, Gerd, Codreanu, Catalin, Da Silva, José Pereira, de Wit, Maarten, Dougados, Maxime, Durez, Patrick, Emery, Paul, Fonseca, João Eurico, Gibofsky, Allan, Gomez-Reino, Juan, Graninger, Winfried, Hamuryudan, Vedat, Jannaut Peῆa, Maria José, Kalden, Joachim, Kvien, Tore K, Laurindo, Ieda, Martin-Mola, Emilio, Montecucco, Carlomaurizio, Santos Moreno, Pedro, Pavelka, Karel, Poor, Gyula, Cardiel, Mario H, Stanislawska-Biernat, Ewa, Takeuchi, Tsutomu, van der Heijde, Désirée
Publicado 2011

Life course body mass index and risk of knee osteoarthritis at the age of 53 years: evidence from the 1946 British birth cohort study

por Wills, Andrew K, Black, Stephanie, Cooper, Rachel, Coppack, Russell J, Hardy, Rebecca, Martin, Kathryn Remmes, Cooper, Cyrus, Kuh, Diana
Publicado 2011

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study

por Braun, Jürgen, Deodhar, Atul, Inman, Robert D, van der Heijde, Désirée, Mack, Michael, Xu, Stephen, Hsu, Benjamin
Publicado 2011

Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab

por Wagner, Carrie, Visvanathan, Sudha, Braun, Jürgen, van der Heijde, Désirée, Deodhar, Atul, Hsu, Benjamin, Mack, Michael, Elashoff, Michael, Inman, Robert D
Publicado 2011